These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11739070)
1. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Furlan PM; Kallan MJ; Ten Have T; Pollock BG; Katz I; Lucki I Am J Geriatr Psychiatry; 2001; 9(4):429-38. PubMed ID: 11739070 [TBL] [Abstract][Full Text] [Related]
3. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880 [TBL] [Abstract][Full Text] [Related]
4. Relevance of seminal plasma nitric oxide levels and the efficacy of SSRI treatment on lifelong premature ejaculation. Kirecci SL; Simsek A; Yuksel A; Gurdal H; Gurbuz ZG; Usanmaz S Andrologia; 2014 Dec; 46(10):1169-75. PubMed ID: 24354496 [TBL] [Abstract][Full Text] [Related]
5. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692 [TBL] [Abstract][Full Text] [Related]
6. SSRIs do not cause affective blunting in healthy elderly volunteers. Furlan PM; Kallan MJ; Have TT; Lucki I; Katz I Am J Geriatr Psychiatry; 2004; 12(3):323-30. PubMed ID: 15126234 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. Waldinger MD; Zwinderman AH; Olivier B J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492 [TBL] [Abstract][Full Text] [Related]
11. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers. Liston HL; DeVane CL; Boulton DW; Risch SC; Markowitz JS; Goldman J J Clin Psychopharmacol; 2002 Apr; 22(2):169-73. PubMed ID: 11910262 [TBL] [Abstract][Full Text] [Related]
12. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. Stahl SM J Clin Psychiatry; 1998 Dec; 59(12):642-3. PubMed ID: 9921697 [No Abstract] [Full Text] [Related]
13. Serotonergic function in major depression and effect of sertraline and paroxetine treatment. Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074 [TBL] [Abstract][Full Text] [Related]
14. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060 [TBL] [Abstract][Full Text] [Related]
15. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers. Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658 [TBL] [Abstract][Full Text] [Related]